April 2006

ISPOR e-BULLETIN provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to www.ispor.org. Please share these new ISPOR activities with your colleagues.

NEW THIS MONTH

**NEW** ISPOR PRO SIG Responds to the FDA PRO Guidance

**UPDATE** Evidence-Based Medicine Symposium

**NEW** ISPOR 11th Annual International Meeting-UPDATES

**NEW** 2^nd Asia-Pacific Conference Contributed Paper Award Recipients

**NEW** ISPOR Special Interest Group (SIG) - UPDATES

**NEW** 2006 ISPOR Board of Directors Election

**NEW** 23 New Positions at the ISPOR Website

IMPORTANT DATES TO REMEMBER

Ų 25 April 2006 - Early registration deadline ISPOR 11th Annual International Meeting, Marriot Philadelphia, Philadelphia, PA, USA

Ų 20-24 May 2006 - ISPOR 11^th Annual International Meeting, Marriott Philadelphia, Philadelphia, PA, USA

Ų 19 June 2006 - Abstract submission deadline ISPOR 9^th Annual European Congress, 29-31, 2006, Radisson SAS Falconer Hotel & Conference Center, Copenhagen, Denmark

Ų 26 September 2006 - Early registration deadline ISPOR 9^th Annual European Congress, 29-31, 2006, Radisson SAS Falconer Hotel & Conference Center, Copenhagen, Denmark

Ų 29-31 October 2006 - ISPOR 9^th Annual European Congress, Radisson SAS Falconer Hotel & Conference Center, Copenhagen, Denmark

ISPOR ONGOING ACTIVITIES

1. Publications

2. Meetings and Congresses

3. Educational Activities

4. Student News

5. ISPOR Special Interest Groups

6. Committee and Task Force Activities

7. Asia Consortium and Local Chapter News

8. Employment in Pharmacoeconomics and Outcomes Research

9. Membership

1. PUBLICATIONS

Top

VALUE IN HEALTH

Value in Health Volume 9, Issue 2, March/April 2006 TABLE OF CONTENTS at: http://www.ispor.org/valueinhealth_index.asp

VALUE IN HEALTH "ON-LINE EARLY" MANUSCRIPTS

To view these "On-Line Early" articles, simply go to http://www.ispor.org/valueinhealth_index.asp, log on using your membership information, and follow the link.

2. ISPOR MEETINGS AND CONGRESSES

**UPDATE**

EVIDENCE BASED MEDICINE SYMPOSIUM - WHAT DOES IT MEAN? HOW SHOULD REAL WORLD EVIDENCE BE USED FOR RATIONAL DECISION MAKING? WHAT IS THE FUTURE?

Co-sponsored by PhRMA Health Outcomes Committee and ISPOR

Sunday, May 21, 2006, 5:00-7:00PM

Marriott Philadelphia, Philadelphia, PA, USA (Prior to the ISPOR 11th Annual International Meeting)

For more information, go to: http://www.ispor.org/meetings/phila0506/symposium.asp

**UPDATES**

ISPOR 11th ANNUAL INTERNATIONAL MEETING - MAY 20-24, 2006

Marriott Philadelphia, Philadelphia, PA, USA

MONDAY, MAY 22, 2006

1ST PLENARY SESSION: BALANCING AFFORDABILITY AND VALUE: THE UNIVERSAL CHALLENGE IN HEALTH CARE DELIVERY

At: http://www.ispor.org/meetings/phila0506/052206.asp#Plenary1

INVITED ISSUE PANEL: WILL THE QALY SURVIVE?

Monday, May 22, 2006, 11:30-12:30PM

Guest Panelist: Daniel Kahneman PhD, Professor of Psychology and Nobel Prize Recipient; Dennis Fryback PhD, Professor of Population Health Sciences and Industrial Engineering, University of Wisconsin School of Medicine and Public Health; and Alistair McGuire PhD, Professor in Health Economics, London School of Economics.

At: http://www.ispor.org/meetings/phila0506/panels.asp#IP1:_WILL_THE_QALY_SURVIVE_

TUESDAY, MAY 23, 2006

2ND PLENARY SESSION: COMPARATIVE EFFECTIVENESS & HEALTH CARE DECISION-MAKING

At: http://www.ispor.org/meetings/phila0506/052306.asp#Plenary2

WEDNESDAY, MAY 24, 2006

3RD PLENARY SESSION: THE PATIENT VOICE IN MEDICAL PRODUCT EVALUATION: FDA DRAFT GUIDANCE ON MEASURING PATIENT-REPORTED OUTCOMES

At: http://www.ispor.org/meetings/phila0506/052406.asp#Plenary3

POSTER & PODIUMS:

Podium Session I: http://www.ispor.org/meetings/phila0506/052206.asp#pod1

Podium Session II: http://www.ispor.org/meetings/phila0506/052306.asp#pod2

Podium Session III: http://www.ispor.org/meetings/phila0506/052406.asp#pod3

Podium Session IV: http://www.ispor.org/meetings/phila0506/052406.asp#pod4

Poster Session I: http://www.ispor.org/meetings/phila0506/posters1.asp

Poster Session II: http://www.ispor.org/meetings/phila0506/posters2.asp

CONTRIBUTED WORKSHOPS (24 presentations in four sessions):

Session I: http://www.ispor.org/meetings/phila0506/workshops.asp#ws1

Session II: http://www.ispor.org/meetings/phila0506/workshops.asp#ws2

Session III : http://www.ispor.org/meetings/phila0506/workshops.asp#ws3

Session IV : http://www.ispor.org/meetings/phila0506/workshops.asp#ws4

ISSUES PANELS (8 issues panels in two sessions):

Session: I: http://www.ispor.org/meetings/phila0506/panels.asp#ps1

Session II: http://www.ispor.org/meetings/phila0506/panels.asp#ps2

SATELLITE SYMPOSIA:

HANDLING ISSUES AROUND MISSING DATA IN ECONOMIC ANALYSIS sponsored by IMS Health

Monday, May 22, 2006, 1:00-2:00PM

For program, go to: http://www.ispor.org/meetings/phila0506/052206.asp

POWERFUL DATA, MEANINGFUL ANSWERS: AN INTRODUCTION TO THE HEALTH CARE COST & UTILIZATION PROJECT (HCUP) Sponsored by the Agency for Health Care Research and Quality, United States Department of Health and Human Services

Tuesday, May 23, 2006, 7:00-8:00AM

For program, go to: http://www.ispor.org/meetings/phila0506/052306.asp

HEALTH CARE POLICY DEVELOPMENT USING OUTCOMES RESEARCH Sponsored by Jefferson Medical College

Tuesday, May 23, 2006, 1:00-2:00PM

For program, go to: http://www.ispor.org/meetings/phila0506/052306.asp

ISPOR SPECIAL EVENT

ISPOR AT THE HARD ROCK CAFÉ featuring the musical talents of ISPOR members. Be a part of this great networking opportunity! Don't miss out on this one of a kind entertainment experience! Enjoy a buffet complete with appetizers, pasta stations, and dessert. Complimentary drink ticket! Groove to the sounds of the ISPOR Bands!

Monday, May 22, 2006, 8:15-11:30PM

Hard Rock Café, Philadelphia, PA, USA

For details and to register, go to: http://www.ispor.org/meetings/phila0506/party.asp

EARLY REGISTRATION DEADLINE: April 25, 2006

http://www.ispor.org/members/events/closed.asp

HOTEL RESERVATIONS:

Online reservations and additional information at:

http://www.ispor.org/meetings/phila0506/hotel_reservation.asp

SPONSORSHIP OPPORTUNITIES:

Sponsorship Opportunities are available at:

https://www.ispor.org/Exhibit_Sponsor/SponsorshipOpportunities.aspx?event=2

ADVERTISE IN THE FINAL PROGRAM

Advertising deadline: April 13, 2006

http://www.ispor.org/advertising/finalprg.asp

PROFESSIONAL RECRUITMENT CENTER (PRAP)

Advertise employment opportunities:

http://www.ispor.org/prap.asp

For more 11^th Annual Meeting program info, go to: http://www.ispor.org/meetings/phila0506/index.asp

*****************************************************************************************************

ISPOR 2nd ASIA-PACIFIC CONFERENCE

Shanghai, China 5-7 March 2006

The ISPOR 2^nd Asia-Pacific Conference attracted more than 750 attendees from 31 countries on 5 continents!

In addition, the ISPOR 2nd Asia-Pacific Conference was widely announced and reported by Chinese newspapers and journals: Medicine Economics News, Health News, Chinese Health Economic Journal, Health Economic Research, China Pharmacy, and Journal of Health Resources. Below are some of special reports of the Conference (in Chinese):

Articles from Medicine Economic News, 10 March 2006:

Pharmacoeconomics For Health Service

Pharmacoeconomics Around The World

Economic View on Pharmaceutical Evaluation for Disease Management

Pharmacoeconomics Used For Drug Pricing

The Significance of Pharmacoeconomics For Pharmaceutical Marking

Articles from Health News, 14 March 2006

Meeting in Shanghai: Experts From Asia Pacific Discussing Pharmacoeconomics

How Pharmacoeconomics is Used for Health Policy

Pharmacoeconomics Should Be Used For Health Care Decision Making

China Needs Pharmacoeconomics Researcher

China Pharmacoeconomic Guidelines" is Developing

Learn From Others: Pharmacoeconomics Around The World

**NEW**

ISPOR 2nd ASIA-PACIFIC CONFERENCE- BEST CONTRIBUTED PRESENTATION AWARD RECIPIENTS

ISPOR CONTRIBUTED PODIUM PRESENTATION AWARDS:
http://www.ispor.org/awards/2AP.asp#podium

ISPOR CONTRIBUTED POSTER PRESENTATION AWARDS:
http://www.ispor.org/awards/2AP.asp#podium

3. EDUCATION ACTIVITIES

Top

ISPOR SHORT COURSES-PRIOR TO ISPOR 11^TH ANNUAL INTERNATIONAL MEETING - May 2006

Twenty-one short courses including 9 NEW courses will be given this year, with 8 courses on Saturday, May 20, 2006, and 13 courses on Sunday, May 21, 2006.

SATURDAY, MAY 20, 2006

**NEW**

Qualitative Methods for Quality of Life/Patient-Reported Outcomes

Faculty: Carol Tishelman PhD, RN, Associate Professor and Acting Dean, Karolinska Institute, Stockholm, Sweden

For full descriptions of ALL Saturday short courses, please visit: http://www.ispor.org/meetings/phila0506/sc_sat.asp

SUNDAY, MAY 21, 2006

**NEW**

Cost-Effectiveness Analysis alongside Clinical Trials

Faculty: Scott Ramsey MD, PhD, Full Member, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Richard Willke PhD, Senior Director, Group Leader, Global Outcome Research, Worldwide Outcomes Research, US Development Sites Pfizer, Inc., Bridgewater, NJ, USA

**NEW**

Use of Real World Data in Outcomes Research

Faculty: Diana Brixner PhD, RPh, Associate Professor and Department Chair, College of Pharmacy, University of Utah, Salt Lake City, UT, USA; Gregory de Lissovoy, PHD, MPH Senior Research Scientist, Health Analytics Group, United BioSource Corp., Bethesda MD; Daniel M. Huse MA, Practice Leader, Information Products, Thomson Medstat Inc., Cambridge, MA, USA

**NEW**

Bayesian Analysis: Advanced

Faculty: Bryan Luce MBA, PhD, Founder and Senior Research Leader, The MEDTAP Institute at United BioSource Corporation, Bethesda, MD, USA; Christopher S. Hollenbeak PhD, Surgery and Health Evaluation Sciences, Penn State College of Medicine, Hershey, PA, USA; David Vanness PhD, Assistant Professor of Population Health Sciences, University of Wisconsin Medical School, Madison, WI, USA; Keith R Abrams MSc, Professor of Medical Statistics & Course Director, Centre for Biostatistics & Genetic Epidemiology, Department of Health Sciences, University of Leicester, Leicester, UK

**NEW**

Propensity Scores and Comorbidity Risk Adjustment

Faculty: Fadia Shaya MPH, PhD, Assistant Professor/Associate Director, University of Maryland School of Pharmacy, Center on Drugs and Public Policy, Baltimore, MD, USA

**NEW**

Patient Registries: Overview & Application

Faculty: Jeff Trotter MBA, President, Ovation Research Group, Highland Park, IL, USA

**NEW**

Outcomes Research for Medical Devices & Diagnostics

Faculty: Seema Sonnad PhD, Associate Professor, Department of Surgery, University of Pennsylvania, Philadelphia, PA, USA; Stacey Ackerman, MSE, PhD, Vice President,

Covance Market Access Services, San Diego, CA, USA

**NEW**

Case Studies in Pharmaceutical/Biotech Pricing II - Advanced

Faculty: Jack Mycka, President, Optimar Strategic Consulting LLC, Montclair, NJ, USA; Renato Dellamano PhD, President, ValueVector (Value Added Business Strategies), Milan, Italy

**NEW**

Risk Assessment: Analysis and Management

Faculty: Dennis Raisch PhD, Associate Center Director, Scientific Affairs, VA Cooperative Studies Program, Clinical Research Pharmacy, Albuquerque, NM, USA; Anthony Lockett MD, PhD, MBA, Medical Director, ICO, Leeds, UK; Suellen Curkendall PhD, Principal Investigator, Cerner Health Insights, Vienna, VA, USA

For full descriptions of ALL Sunday short courses, please visit: http://www.ispor.org/meetings/phila0506/sc_sun.asp

4. STUDENT NEWS

Top

For more details on the ISPOR Student Network, please visit: http://www.ispor.org/student/student_index.asp

5. ISPOR SPECIAL INTEREST GROUPS (SIG)

Top

SPECIAL INTEREST GROUPS are very important to ISPOR to achieve its mission. Their goals are to: develop consensus; stimulate debate; advance knowledge/understanding; publish good research practices; develop indices & tools for researchers and decision-makers; compile health care information for public; respond to health care public policy.

PATIENT REPORTED OUTCOMES SIG

**NEW**

The ISPOR PRO/QOL Information in Regulatory & Health Care Decisions working group responds to the Patient-reported Outcomes Draft FDA Guidance.

The ISPOR PRO Special Interest Group (SIG) Chair, the Chair and members of the PRO/QOL Information in Regulatory & Health Care Decisions working group, as well as the Chairs of the ePRO working group and the Cross cultural & Translational Adaptation working group, developed the response to the Patient-reported Outcomes Draft FDA Guidance. The response was based on comments and suggestions received from over 50 ISPOR members.

The ISPOR response submitted to the FDA can be viewed at http://www.ispor.org/workpaper/ISPOR%20Response%20to%20FDA%20PRO%20Guidance.pdf

The Draft FDA Guidance can be viewed at http://www.ispor.org/workpaper/FDA%20PRO%20Guidance.pdf

TRANSLATING RESEARCH TO PRACTICE SIG

**NEW**

Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions - SURVEY

The ISPOR Translating Research To Practice Special Interest Group is conducting a survey on health care decision making.

If you make decisions on any drug formulary selections processes, any decisions on drugs, medical device or diagnostics treatments for others, we invite you to participate in this brief survey.

To go to the survey, go to: http://www.ispor.org/surveys/TRP_SIG/default.asp

For more information and to join an ISPOR SIG, go to http://www.ispor.org/sigs/sigsindex.asp. The ISPOR SIGs are:

EVIDENCE-BASED REIMBURSEMENT SIG

TRANSLATING RESEARCH TO PRACTICE SIG

PATIENT REGISTRY SIG

PATIENT REPORTED OUTCOMES SIG

MEDICATION COMPLIANCE & PERSISTENCE SIG

RETROSPECTIVE DATABASE SIG

RISK MANAGEMENT SIG

6. ISPOR BOARD, COMMITTEE, AND TASK FORCE ACTIVITIES

Top

COMMITTEE ACTIVITIES

**NEW**

2006 ISPOR Board of Directors Election

The International Society for Pharmacoeconomics and Outcomes Research is a member-driven organization. Your participation is critical. The activities of the organization are in response to member needs. As a member-driven organization, its governance is determined by the membership.

The 2006 ISPOR Board of Directors ballot can be found at: http://www.ispor.org/members/elections/elect2006.asp

President-Elect Candidates

Diana Brixner PhD

Judith A. O’Brien, RN, BSPA

Director (Position 1) Candidates

Claude Le Pen PhD

Uwe Siebert MD, MPH, MSc, ScD

Director (Position 2) Candidates

Shanlian Hu MD, MSc

Shu-Chuen Li, BPharm, Cert Health Econ., Grad Dip Bus (Tech Mgt), MApplSc, MBA, PhD

Director (Position 3) Candidates

Marc L. Berger MD

Kathleen A. Weis, Dr.PH, PhD, MSN, ENP/FNP

Election ballot must be received by MAY 1, 2006.

TASK FORCE ACTIVITIES

BUDGET IMPACT ANALYSIS TASK FORCE

The Task Force just ended an intensive face-to-face meeting where all details in the Task Force Report were finalized. Pending review, the Task Force will present their Good Practices Report for publication this summer.

The BIA Task Force will also present the report process, themes and projections during the forum, “Issues in Assessing Good Practice Guidelines for Budget Impact Analyses,” at the ISPOR 11^th Annual International Meeting in Philadelphia, PA, USA, on May 22, 2006, at 4:30 PM.

For information, go to: http://www.ispor.org/workpaper/budget_impact.asp

7. ASIA CONSORTIUM AND LOCAL CHAPTER NEWS

Top

For more details on ISPOR Local Chapters, go to: http://www.ispor.org/local_chapters/index.asp

ISPOR ASIA CONSORTIUM

For more details on this consortium, please visit: http://www.ispor.org/consortiums/asia.asp

LOCAL CHAPTER NEWS

BRAZIL CHAPTER

The newly approved ISPOR Brazil Local Chapter held their first meeting in Sćo Paulo this March. Elections were held and an ambitious plan solidified the direction of chapter activities. To find out more, go to: http://www.ispor.org/local_chapters/Brazil/index.asp

CHINESE MEDICAL DOCTORS ASSOCIATION PHARMACOECONOMIC (MDA-PE) CHAPTER

The newly approved ISPOR Chinese Medical Doctors Association-Pharmacoeconomics (MDA-PE) Chapter includes key pharmacoeconomics academicians in China. For more information on this chapter, go to: http://www.ispor.org/local_chapters/China/index.asp

TURKISH SOCIETY OF CLINICAL PHARMACOLOGY (SCP) CHAPTER

The ISPOR Turkish SCP Chapter has been established as a sub-organization of the Turkish Society of Clinical Pharmacology to improve the knowledge of pharmacoeconomics and to introduce it into the drug regulation-approval-reimbursement procedures in Turkey. To find out more, go to: http://www.ispor.org/local_chapters/Turkey/index.asp

8. EMPLOYMENT

Top

**NEW**

23 NEW POSITIONS AT THE ISPOR WEBSITE: http://www.ispor.org/employment/employment_index.asp

Advertise your positions on ISPOR Website (~1 million hits per month)

INTERNSHIPS

Visit ISPOR's Internship-Professional Recruitment Assistance Program (I-PRAP) at http://www.ispor.org/iprap/index.asp. STUDENTS: Post your CVs/resumes for employers to view and search for internship positions available. Nine student resumes posted! EMPLOYERS: Post your Intern positions for FREE and access CVs/resumes from students. If you have any questions, please contact: iprap@ispor.org. For more information, visit our website at http://www.ispor.org/prap.asp

9. ISPOR MEMBERSHIP

Top

Update your email address at https://www.ispor.org/members/addresschange.asp! Your email address is required as part of your log in information in the members only section of the ISPOR website.